Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Cancelled
Biotech

Nuvig halts development of lead drug for rare autoimmune disease

While a ph. 2 trial in CIDP has stopped, development in ITP is still ongoing, and Nuvig intends to pursue more diseases with NVG-2089.
Darren Incorvaia Oct 6, 2026 2:48pm
ion channel sodium channel

Mimetic’s peptide shows promise in reducing neuropathic pain

Oct 6, 2026 11:00am
How to Choose a Biologics CDMO 4 Criteria That Matter the Most

4 Criteria for Choosing the Right Biologics CDMO

Brought to you by Rezon Bio
Lung

ArriVent’s phase 3 lung cancer trial flops, sinking stock

Oct 6, 2026 10:51am
shutterstock25078614631png

There Is No Such Thing as a Typical Biotech

Brought to you by Syneos Health
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: KymaThera & more

Oct 6, 2026 10:15am